Literature DB >> 24838302

Inflammation: a mechanism of depression?

Qiu-Qin Han1, Jin Yu.   

Abstract

In recent decades, major depression has become more prevalent and research has shown that immune activation and cytokine production may be involved. This review is mainly focused on the contribution of inflammation to depression. We first briefly introduce the inflammatory biomarkers of depression, then discuss the sources of cytokines in the brain, and finally describe the neuroimmunological mechanisms underlying the association between inflammation and depression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838302      PMCID: PMC5562613          DOI: 10.1007/s12264-013-1439-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  104 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?

Authors:  H-Q Wu; A Rassoulpour; R Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

3.  Ketamine for the treatment of depression.

Authors:  Robert H Howland
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2013-01       Impact factor: 1.098

4.  Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.

Authors:  Christian Friedrich Jehn; Dagmar Kühnhardt; Andrea Bartholomae; Sebastian Pfeiffer; Peter Schmid; Kurt Possinger; Bernd Christian Flath; Diana Lüftner
Journal:  Integr Cancer Ther       Date:  2010-05-11       Impact factor: 3.279

5.  Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder.

Authors:  Shima Jazayeri; Seyed A Keshavarz; Mehdi Tehrani-Doost; Mahmood Djalali; Mostafa Hosseini; Homayoun Amini; Maryam Chamari; Abolghassem Djazayery
Journal:  Psychiatry Res       Date:  2010-05-13       Impact factor: 3.222

6.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death.

Authors:  R M Sapolsky
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

7.  Cytokines and serotonin transporter in patients with major depression.

Authors:  Chiung-Wen Tsao; Yee-Shin Lin; Chwen-Cheng Chen; Chyi-Huey Bai; Shin-Rung Wu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-03-06       Impact factor: 5.067

8.  Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier.

Authors:  Tomitsune Kitagami; Kiyofumi Yamada; Hideki Miura; Ryo Hashimoto; Toshitaka Nabeshima; Tatsurou Ohta
Journal:  Brain Res       Date:  2003-07-18       Impact factor: 3.252

Review 9.  Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets.

Authors:  G Z Feuerstein; X Wang; F C Barone
Journal:  Ann N Y Acad Sci       Date:  1997-10-15       Impact factor: 5.691

10.  Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway.

Authors:  M Elizabeth Sublette; Teodor T Postolache
Journal:  Psychosom Med       Date:  2012-08-24       Impact factor: 4.312

View more
  21 in total

1.  Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine.

Authors:  Lu Dong; Baoman Li; Alexei Verkhratsky; Liang Peng
Journal:  Psychopharmacology (Berl)       Date:  2015-04-09       Impact factor: 4.530

Review 2.  Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Authors:  Christian Herder; Norbert Hermanns
Journal:  Semin Immunopathol       Date:  2019-02-18       Impact factor: 9.623

3.  The role of microglia in mediating the effect of the environment in brain plasticity and behavior.

Authors:  Igor Branchi; Silvia Alboni; Laura Maggi
Journal:  Front Cell Neurosci       Date:  2014-11-18       Impact factor: 5.505

Review 4.  New hypothesis and treatment targets of depression: an integrated view of key findings.

Authors:  Shangli Cai; Shucai Huang; Wei Hao
Journal:  Neurosci Bull       Date:  2015-01-09       Impact factor: 5.203

5.  Association of Depression, Antidepressants With Atrial Fibrillation Risk: A Systemic Review and Meta-Analysis.

Authors:  Yonghui Fu; Shenghui Feng; Yingxiang Xu; Yuanjian Yang; Haibo Chen; Wenfeng He; Wengen Zhu; Kang Yin; Zhengbiao Xue; Bo Wei
Journal:  Front Cardiovasc Med       Date:  2022-05-11

Review 6.  Suggested Biomarkers for Major Depressive Disorder.

Authors:  Yunus Hacimusalar; Ertuğrul Eşel
Journal:  Noro Psikiyatr Ars       Date:  2018-05-28       Impact factor: 1.339

Review 7.  Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression.

Authors:  Ferenc Zádor; Sâmia Joca; Gábor Nagy-Grócz; Szabolcs Dvorácskó; Edina Szűcs; Csaba Tömböly; Sándor Benyhe; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 8.  Vitamin D and inflammation.

Authors:  John J Cannell; William B Grant; Michael F Holick
Journal:  Dermatoendocrinol       Date:  2015-01-29

9.  The risk of depression in patients with cholelithiasis before and after cholecystectomy: a population-based cohort study.

Authors:  Te-Chun Shen; Hsueh-Chou Lai; Yu-Jhen Huang; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

10.  Relationship Between Serum Vitamin D Levels and Symptoms of Depression in Stroke Patients.

Authors:  Sang-Hyun Kim; Hyun Seok; Dong Suk Kim
Journal:  Ann Rehabil Med       Date:  2016-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.